Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18922938)

  • 1. Agglomerative epigenetic aberrations are a common event in human breast cancer.
    Novak P; Jensen T; Oshiro MM; Watts GS; Kim CJ; Futscher BW
    Cancer Res; 2008 Oct; 68(20):8616-25. PubMed ID: 18922938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.
    Dallosso AR; Hancock AL; Szemes M; Moorwood K; Chilukamarri L; Tsai HH; Sarkar A; Barasch J; Vuononvirta R; Jones C; Pritchard-Jones K; Royer-Pokora B; Lee SB; Owen C; Malik S; Feng Y; Frank M; Ward A; Brown KW; Malik K
    PLoS Genet; 2009 Nov; 5(11):e1000745. PubMed ID: 19956686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Methylation Analysis of the PCDHB Gene Cluster.
    Banelli B; Romani M
    Methods Mol Biol; 2015; 1315():189-200. PubMed ID: 26103900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development.
    Liang P; Song F; Ghosh S; Morien E; Qin M; Mahmood S; Fujiwara K; Igarashi J; Nagase H; Held WA
    BMC Genomics; 2011 May; 12(1):231. PubMed ID: 21569359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic exercise training resets the human skeletal muscle methylome 10 years after breast cancer treatment and survival.
    Gorski PP; Raastad T; Ullrich M; Turner DC; Hallén J; Savari SI; Nilsen TS; Sharples AP
    FASEB J; 2023 Jan; 37(1):e22720. PubMed ID: 36542473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
    Versmold B; Felsberg J; Mikeska T; Ehrentraut D; Köhler J; Hampl JA; Röhn G; Niederacher D; Betz B; Hellmich M; Pietsch T; Schmutzler RK; Waha A
    Int J Cancer; 2007 Aug; 121(3):547-54. PubMed ID: 17415710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustered protocadherins methylation alterations in cancer.
    Vega-Benedetti AF; Loi E; Moi L; Blois S; Fadda A; Antonelli M; Arcella A; Badiali M; Giangaspero F; Morra I; Columbano A; Restivo A; Zorcolo L; Gismondi V; Varesco L; Bellomo SE; Giordano S; Canale M; Casadei-Gardini A; Faloppi L; Puzzoni M; Scartozzi M; Ziranu P; Cabras G; Cocco P; Ennas MG; Satta G; Zucca M; Canzio D; Zavattari P
    Clin Epigenetics; 2019 Jul; 11(1):100. PubMed ID: 31288858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placentas from pregnancies conceived by IVF/ICSI have a reduced DNA methylation level at the H19 and MEST differentially methylated regions.
    Nelissen EC; Dumoulin JC; Daunay A; Evers JL; Tost J; van Montfoort AP
    Hum Reprod; 2013 Apr; 28(4):1117-26. PubMed ID: 23343754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG island hypermethylation in human astrocytomas.
    Wu X; Rauch TA; Zhong X; Bennett WP; Latif F; Krex D; Pfeifer GP
    Cancer Res; 2010 Apr; 70(7):2718-27. PubMed ID: 20233874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXD13 methylation status is a prognostic indicator in breast cancer.
    Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
    Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.
    Zhou X; Chen Z; Cai X
    Epigenetics; 2018; 13(5):473-489. PubMed ID: 29940789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylation on expression of TMS1/ASC in human breast cancer cells.
    Levine JJ; Stimson-Crider KM; Vertino PM
    Oncogene; 2003 May; 22(22):3475-88. PubMed ID: 12776200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.